File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treatment of hepatitis B

TitleTreatment of hepatitis B
Authors
Cheung, TKLai, CL
Issue Date2004
PublisherHong Kong College of Family Physicians. The Journal's web site is located at http://www.hkcfp.org.hk/
Citation
Hong Kong Practitioner, 2004, v. 26 n. 7, p. 309-314 How to Cite?
AbstractMore than 400 million people worldwide are chronically infected by the hepatitis B virus and the majority of these are Asians. Major breakthroughs have been achieved in the diagnosis and treatment of this virus. The currently available therapeutic agents include interferon, lamivudine, and adefovir dipivoxil. They rarely eradicate the virus, but greatly reduce its replication, necroinflammatory histological activity, and the progression of liver fibrosis. Their indications and uses are discussed in detail in this article. Some of the therapeutic agents under clinical trials at present are also described.
Persistent Identifierhttp://hdl.handle.net/10722/76477
ISSN
1027-3948
2020 SCImago Journal Rankings: 0.101
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorCheung, TKen_HK
dc.contributor.authorLai, CLen_HK
dc.date.accessioned2010-09-06T07:21:39Z-
dc.date.available2010-09-06T07:21:39Z-
dc.date.issued2004en_HK
dc.identifier.citationHong Kong Practitioner, 2004, v. 26 n. 7, p. 309-314en_HK
dc.identifier.issn1027-3948en_HK
dc.identifier.urihttp://hdl.handle.net/10722/76477-
dc.description.abstractMore than 400 million people worldwide are chronically infected by the hepatitis B virus and the majority of these are Asians. Major breakthroughs have been achieved in the diagnosis and treatment of this virus. The currently available therapeutic agents include interferon, lamivudine, and adefovir dipivoxil. They rarely eradicate the virus, but greatly reduce its replication, necroinflammatory histological activity, and the progression of liver fibrosis. Their indications and uses are discussed in detail in this article. Some of the therapeutic agents under clinical trials at present are also described.en_HK
dc.languageengen_HK
dc.publisherHong Kong College of Family Physicians. The Journal's web site is located at http://www.hkcfp.org.hk/en_HK
dc.relation.ispartofHong Kong Practitioneren_HK
dc.titleTreatment of hepatitis Ben_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1027-3948&volume=26&spage=309&epage=314&date=2004&atitle=Treatment+of+Hepatitis+Ben_HK
dc.identifier.emailLai, CL:hrmelcl@hku.hken_HK
dc.identifier.authorityLai, CL=rp00314en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.scopuseid_2-s2.0-4744342554en_HK
dc.identifier.hkuros130231en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-4744342554&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume26en_HK
dc.identifier.issue7en_HK
dc.identifier.spage309en_HK
dc.identifier.epage314en_HK
dc.publisher.placeHong Kongen_HK
dc.identifier.scopusauthoridCheung, TK=7103334158en_HK
dc.identifier.scopusauthoridLai, CL=7403086396en_HK
dc.identifier.issnl1027-3948-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats